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Abstract 
 We determined the difference in the skin-penetration enhancing effects of 
conventional (C-) and super-refined (SR-) isopropyl fatty acids (IPFAs) including 
isopropyl myristate (IPM), isopropyl palmitate (IPP), and isopropyl oleate (IPO). In vitro 
permeation experiments were performed with excised hairless rat skin using a model mal-
absorbed chemical, calcein. As a result, SR-IPM pretreatment markedly increased the 
skin permeation of calcein from aqueous solution more than C-IPM pretreatment, in spite 
of a small difference in IPM purity (98.78 vs 99.96%). Similar phenomena were recorded 
even when using SR-IPM emulsion compared with C-IPM emulsion without pretreatment. 
In contrast, C-IPP pretreatment showed higher skin permeation than SR-IPP. In addition, 
no difference was observed in skin permeation between C-IPO and SR-IPO. Skin 
impedance was also determined as an index of skin barrier function. SR-IPM changed the 
skin barrier function more than C-IPM, which supported the penetration-enhancing order 
of C-IPM and SR-IPM shown above. It was unexpected to find such a big difference in 
the skin-penetration enhancing effect of C-IPM vs SR-IPM and C-IPP vs SR-IPP. The 
present results suggested that SR-IPM could be a promising ingredient in pharmaceutical 
and cosmetic products for topical use. 
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Searching for potent skin-penetration enhancers is a key issue in the 
development of new topical and transdermal drug delivery systems. Through many 
previous exploratory studies, a variety of delivery systems containing chemical 
enhancer(s) have been developed. However, it has become more difficult to find new 
potent enhancers over the past decade or two, which suggests that the present 
methodology and ideas are not sufficient to find good skin-penetration enhancers. Several 
researchers have already applied physical enhancement methods such as iontophoresis 
and microneedle puncture with chemical enhancers [1,2]. A combination of two or more 
chemical enhancers is also useful to further increase the skin permeation of drugs [3-5]. 
Because the purity of most enhancers in previous studies has not been 100.0%, these 
studies even using single enhancers may be thought of as examining the effect of a kind 
of enhancer mixture. We then paid attention to the purity level of the enhancers. 
Isopropyl fatty acids (IPFAs) such as isopropyl myristate (IPM), isopropyl 
palmitate (IPP), and isopropyl oleate (IPO) are major ingredients (as skin penetration 
enhancers) in topical and transdermal delivery systems as well as cosmetic products. IPM 
is the most used among such fatty acid esters, and it was expected to especially enhance 
the penetration of active chemicals through the skin [4,6]. The previous experiments were 
done using crude IPFAs (such as IPM) as described above. Nowadays, super-refined 
IPFAs are available as a result of the rapid progress in purification technology for IPFAs. 
This technology using column chromatographic purification physically removes primary 
impurities to have super-refined IPFAs (SR-IPFAs). The impurities in the conventional 
IPFAs (C-IPFAs; such as IPM) may be related to the increased skin irritation and 
decreased stability as well as lowering the penetration enhancing ability of drugs through 
the skin. 
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In the present study, the effect of SR-IPFAs especially SR-IPM on the skin-
penetration enhancing effect was investigated to reveal the usefulness of newly developed 
SR-IPFAs compared with C-IPFAs using a conventional in vitro skin permeation 
experiment and skin impedance determination. The purity of C-IPM used in this 
experiment was 98.78%, whereas that of SR-IPM was 99.96% (Table 2). 
 
I. MATERIALS AND METHODS 
1. Materials 
C-IPM, SR-IPM, C-IPP, SR-IPP, C-IPO, SR-IPO, and the mixture of impurities 
remaining in the column after the purification process were gifts from Croda Japan 
(Tokyo, Japan). Other reagents and solvents were of analytical grade and used without 
further purification. Table 1 shows the chemical structures and molecular weights (M.W.) 
of the chemicals analyzed. Table 2 compares impurities in the C-IPM and SR-IPM used 
in this experiment. 
 
Tables 1 and 2 
 
2. Experimental animals 
Male hairless rats (WBM/ILA-Ht, 7–9 weeks old, body weight: 200–250 g) were 
purchased from either Life Science Research Center, Josai University (Sakado, Saitama, 
Japan) or Ishikawa Experiment Animal Laboratories (Fukaya, Saitama, Japan). They 
were housed in temperature-controlled rooms (25 ± 2°C) with a 12 h light-dark cycle 
(7:00–19:00 h). The rats were allowed free access to food (Oriental Yeast Co. Tokyo, 
Japan) and tap water. All breeding procedures and the experiments on animals were 
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performed in accordance with the guideline of the Animal Experiment Committee of Josai 
University. 
 
3. Preparation of formulations 
Oil-in-water (O/W) emulsions containing calcein as a model mal-absorbed 
hydrophilic penetrant were prepared with 30% (v/v) C-IPFAs or SR-IPFAs and 0.1% 
(v/v) polysorbate (Tween) 80 as an emulsifier. The mixture of IPFA and Tween 80 was 
added slowly to calcein in pH 7.4 phosphate-buffered saline–EDTA solution (PBS-
EDTA). The obtained solution was agitated thoroughly at 14,000 rpm for 5 min using a 
Polytron PT3100 (Kinematica AG, Littau-Lucerne, Switzerland) to obtain O/W 
emulsions. 
 
4. In vitro skin permeation experiment 
4.1. In vitro skin permeation of calcein from PBS-EDTA after pretreatment with SR-
IPFA 
Abdominal full-thickness skin from hairless rats was excised under anesthesia 
by i.p. injection of medetomidine (0.375 mg/kg), butorphanol (2.5 mg/kg), and 
midazolam (2 mg/kg), and excess subcutaneous fat and blood was carefully removed.  
Then, the hairless rats were sacrificed immediately by injection of pentobarbital sodium 
salt (40 mg/kg). The stratum corneum surface of the skin (application area; 0.95 cm2) was 
pretreated with 3.0 mL of IPFAs for 1 h. Then, the pretreated skin was wiped and washed 
with PBS-EDTA to remove excess IPFAs from the skin surface. The skin piece was 
mounted in a side-by-side diffusion cell with an effective diffusion area of 0.95 cm2 [7]. 
Then, 0.1 M calcein solution (3.0 mL) was placed on the stratum corneum side of the skin. 
6 
 
The receiver solution was 3.0 mL of PBS-EDTA, which was maintained at 32°C using a 
thermo-regulated water bath. A magnetic stirrer bar was added in the donor and receiver 
compartments, which moved at about 1,200 rpm throughout the experiment. The receiver 
solution samples (0.5 mL) were withdrawn every 1 h, and the same volume of PBS-EDTA 
was added to the receiver compartment to keep the volume constant. 
4.2. In vitro skin permeation experiment with calcein from O/W emulsion without 
pretreatment 
The O/W emulsion (3.0 mL) containing calcein with C-IPFA or SR-IPFA was 
placed on the stratum corneum side of the skin (without pretreatment) in the side-by-side 
diffusion cell, as above. The other methods were the same as above. 
4.3. Determination of calcein 
Each receiver sample was examined for calcein using a fluorospectrophotometer 
(RF 5300PC, Shimadzu, Kyoto, Japan) at an excitation wavelength of 488 nm and 
fluorescent emission wavelength of 515 nm. 
 
5. Skin impedance determination 
Pretreated abdominal full-thickness skin of hairless rats by C-IPM or SR-IPM or 
O/W emulsion containing each IPM was mounted in a side-by-side diffusion cell as above. 
The donor and receiver solutions were 3.0 mL of PBS, which was maintained at 32°C 
using a thermo-regulated water bath. Both solutions were stirred using a magnetic stirrer 
bar at about 1,200 rpm throughout the experiment. Skin impedance was determined using 
an impedance meter (10 Hz AC, Advance, Tokyo, Japan) at various intervals over 2 h. 
 
6. Statistical analysis 
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 Statistical analysis was performed using an unpaired Student’s t-test. A p value 
less than 0.05 was considered significant. 
 
II. RESULTS 
1. Effect of C-IPFAs and SR-IPFAs on the in vitro skin permeation of calcein 
Figure 1 shows the pretreatment effect of C-IPFAs and SR-IPFAs on the time 
course of the cumulative amount of calcein that permeated from PBS-EDTA through 
excised full-thickness hairless rat skin. Figures 1a, b and c show the results for IPM, IPP, 
and IPO pretreatment, respectively. PBS-EDTA was pretreated as a control. Permeation 
experiments were done using calcein in PBS-EDTA after one of these three pretreatments 
(pretreated by C-IPFAs or SR-IPFAs or PBS-EDTA). Pretreatment with C-IPM slightly 
enhanced the skin permeation of calcein compared with a control solvent, PBS-EDTA. 
In contrast, pretreatment with SR-IPM markedly enhanced the skin permeation of calcein 
compared with C-IPM. When evaluated statistically, the cumulative amount of skin 
permeation over 8 h, a significant difference was observed between these two groups. On 
the other hand, C-IPP showed a much higher enhancing effect than that with SR-IPP, and 
significant difference was observed between them. It was also of note in the case of IPO 
that there was little difference in the skin permeation of calcein between with C-IPO and 
SR-IPO. 
 
Fig. 1 
 
Figure 2 shows the effect of IPFA-containing O/W emulsion on the time course 
of the cumulative amount of calcein that permeated through excised full-thickness 
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hairless rat skin without any pretreatment. Tween 80 at a concentration of 0.1% was used 
to prepare the O/W emulsion, so the same concentration of Tween 80 as well as PBS-
EDTA were used as the calcein donor solution. The C-IPM emulsion enhanced the skin 
permeation of calcein compared with PBS-EDTA, but the effect was not different from 
that of Tween 80 solution, suggesting that the effect for the C-IPM emulsion may be 
dependent on Tween 80 in the emulsion. On the other hand, the SR-IPM emulsion 
markedly increased the skin permeation of calcein. A significant difference was observed 
for the cumulative permeation over 8 h between the C-IPM and SR-IPM groups. 
No enhancing effect was observed on the skin permeation of calcein with C-IPP 
and SR-IPP emulsions. In contrast, C-IPO and SR-IPO emulsions increased skin 
permeation, but the effect was much lower than with SR-IPM emulsion. 
 
Fig. 2 
 
 Because both SR-IPM and its emulsion markedly increased the in vitro skin 
permeation of calcein compared with C-IPM, other IPFAs and their emulsions, the 
following experiments were done using only C-IPM and SR-IPM. 
 
2. Effect of C-IPM and SR-IPM on skin impedance 
Skin impedance was found to be directly related to the skin permeability of 
hydrophilic compounds [8]. To further evaluate the positive enhancing effect of SR-IPM 
rather than C-IPM, skin was pretreated with C-IPM or SR-IPM or their O/W emulsions 
for 60 min. Table 3 shows results for the impedance change (% against that before 
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pretreatment). The skin impedance changes after pretreatment with SR-IPM and SR-IPM 
emulsion were significantly greater than those for C-IPM and its emulsion, respectively. 
 
Table 3 
 
III. DISCUSSION AND CONCLUSION 
It was of particular interest in the present study that SR-IPM pretreatment 
markedly increased the skin permeation of calcein more than C-IPM pretreatment (Fig. 
1a), in spite of only a small difference in IPM purity (98.78 vs 99.96%). A similar 
phenomenon was observed even when using SR-IPM emulsion than C-IPM emulsion 
(Fig. 2a). In contrast, C-IPP pretreatment showed higher skin permeation than SR-IPP 
(Fig. 1b). In addition, no difference was observed on the skin permeation by the C- and 
SR-IPO (Fig. 2b). It will be important to evaluate why C-IPP showed higher skin 
permeation than SR-IPP. In the present study, however, we just focused on the higher 
skin-penetration enhancing effect of SR-IPM, because our main focus was to find a good 
enhancer system or to establish a good searching method for chemical enhancers. 
The present results shown in Figures 1a and 2a suggested that impurities in C-
IPM decreased skin permeation. Then, a pretreatment experiment on skin was done by 
the addition of impurities (at a concentration of 5%) obtained in the column 
chromatographic purification process from C-IPM into the SR-IPM specimen. As a result, 
skin permeation was decreased to a similar level as for C-IPM pretreatment (Fig. 3). 
Further experiments will be needed with changing impurity concentrations. Higher fatty 
acids, such as dodecanoic acid and tridecanoic acid, and fatty acid esters with similar total 
carbon numbers, such as butyl myristate and IPP, were found in the impurities in C-IPM 
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(Table 2). Because IPP, one of the impurities in C-IPM, had little enhancement effect on 
the skin permeation of calcein, as shown in Figures 2b and 3b, the higher effect of SR-
IPM than C-IPM may not be surprising. 
The result of skin impedance determination (Table 3) showed that SR-IPM 
changed the skin barrier function more than C-IPM. This result supported the penetration-
enhancing order of C-IPM and SR-IPM in Figures 1a and 2a. Several mechanisms such 
as lipid extraction, phase separation, inverted micelle formation, or bilayer fluidization 
[9] may be related to the skin impedance change with SR-IPM. In addition, these are also 
related to the penetration-enhancing effect of SR-IPM. The effect of pure IPM and several 
impurities must be evaluated separately. 
We believe that few researchers would expect such a big difference in the skin-
penetration enhancing effects with C-IPM vs SR-IPM and C-IPP vs SR-IPP. Further 
attention will be needed on the use of crude chemical enhancers, and we have to compare 
the enhancing effect between crude and pure chemicals when extraordinarily pure 
chemicals are available. 
The present results suggested that newly developed SR-IPM could be a 
promising ingredient in pharmaceutical and cosmetic products for topical use. Further 
studies will need to be conducted to evaluate the usefulness of SR-IPFAs in 
pharmaceutical and cosmetic applications. 
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Figure captions 
 
Figure 1. Effect of C-IPFA and SR-IPFA pretreatment on the time course of the 
cumulative amount of calcein permeating through full-thickness hairless rat skin from 
its aqueous solution. 
Figures 1a, b and c show for IPM, IPP, and IPO, respectively. Symbols: C-IPFAs (); 
SR-IPFAs (●); PBS-EDTA (▲). Significant difference was observed between C-IPM 
and SR-IPM and between C-IPP and SR-IPP. Each point represents the mean ± S.D. (n 
= 3 - 12). 
 
Figure 2. Effect of C-IPFA and SR-IPFA emulsions on the time course of the 
cumulative amount of calcein permeating through full-thickness hairless rat skin 
without pretreatment.  
Figures 2a, b and c show for IPM, IPP, and IPO, respectively. Symbols: C-IPFAs (); 
SR-IPFAs (●); 0.1% Tween 80 (△); PBS-EDTA (▲). Significant difference was 
observed between C-IPM and SR-IPM emulsions. Each point represents the mean ± 
S.D. (n = 3 - 19). 
 
Figure 3. Effect of impurities on the time course of the cumulative amount of calcein 
permeating through full-thickness hairless rat skin.  
Symbols: C-IPM (); SR-IPM(●); impurities spiked SR-IPM (); PBS-EDTA (▲). 
Each point represents the mean ± S.D. (n = 3 - 12). 
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Table 1 Structure and molecular weight of IPFAs used in the present study 
  
IPFAs Abbreviation 
Molecular formula 
M.W. 
Isopropyl 
myristate 
C-IPM 
 
270.5 SR-IPM 
Isopropyl 
palmitate 
C-IPP 
 
298.5 SR-IPP 
Isopropyl 
oleate 
C-IPO 
 
324.5 SR-IPO 
O
O
O
O
O
O
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Table 2 Impurities in C-IPM and SR-IPM 
 C-IPM SR-IPM 
Benzenesulfonic acid 0 0 
Dodecanoic acid 0.24 0 
Tridecanoic acid 0.21 0.01 
Tetradecanoic acid 0 0 
Isopropyl 13-
methyltetradecanoate 
0 0 
Butyl myristate 0.03 0 
Isopropyl palmitate 0.74 0 
Unidentified compounds 0 0.03 
Total (impurity) 1.22% 0.04% 
These values are for the C-IPM and SR-IPM used in this experiment. 
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Table 3 Skin impedance change after 60-min application of C-IPM or SR-IPM or one of 
their emulsions 
 Impedance ratio (%) 
C-IPM 45.8 ± 8.3 
SR-IPM 25.6 ± 4.4* 
C-IPM emulsion 83.5 ± 5.5 
SR-IPM emulsion 63.6 ± 8.2* 
Impedance before application was set to 100%. Each value represents the mean ± S.D. 
(n = 5). *Significant difference was observed between C-IPM and SR-IPM and between 
C-IPM and SR-IPM emulsions. 
